Почетна › Алцхајмерова болест › Тексас
Kliničke studije za Алцхајмерова болест u državi Тексас
38 studija za Алцхајмерова болест traži učesnike na lokacijama u državi Тексас.
Gradovi u državi Тексас
- Dallas12 студија
- Houston11 студија
- Austin10 студија
- San Antonio8 студија
- Cypress7 студија
- Beaumont6 студија
- El Paso4 студија
- Round Rock3 студија
Zvanični tekst studije (na engleskom)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Austin
- Clinical Site, McKinney
- Clinical Site, Sugarland
Тражи се учесникФаза 2
Узраст од 55 до 90 · Оба пола · Ажурирано 12. 11. 2026. · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Epic Medical Research, LLC - Carrolton, Carrollton
- Horizon Clinical Research Center - Houston, Cypress
- Advanced Neurology Epilepsy and Sleep Center, El Paso
- и још 2
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 12. 11. 2026. · NCT06937229A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Advanced Neurology Epilepsy and Sleep Center, El Paso
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 6. 11. 2026. · NCT07011732A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Kerwin Medical Center- Site Number : 8400006, Dallas
Тражи се учесникФаза 2
Узраст од 55 до 85 · Оба пола · Ажурирано 6. 11. 2026. · NCT07688213Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
- Houston Methodist Research Institute, Houston
Тражи се учесникФаза 1/2
Узраст од 50 до 86 · Оба пола · Ажурирано 6. 11. 2026. · NCT07651319A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Gadolin Research, Beaumont
- Kerwin Medical Center, Dallas
- Houston Methodist Hospital, Houston
- и још 3
Тражи се учесникФаза 2
Узраст од 55 до 85 · Оба пола · Ажурирано 4. 11. 2026. · NCT07589595A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Epic Medical Research, LLC - Carrolton, Carrollton
- Horizon Clinical Research Center - Houston, Cypress
- Epic Medical Research, LLC - Mesquite, Mesquite
- и још 1
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 3. 11. 2026. · NCT07011745A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Horizon Clinical Research Group, Cypress
Тражи се учесникФаза 2
Узраст 55 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06540833A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Senior Adults Specialty Research, Austin
- Gadolin Research, Beaumont
- The University of Texas Health Science Center at Houston, Houston
- и још 1
Тражи се учесникФаза 3
Узраст 55 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07602582A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Gadolin Research, Beaumont
Тражи се учесникФаза 3
Узраст од 60 до 85 · Оба пола · Ажурирано 27. 10. 2026. · NCT06976216A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Senior Adults Specialty Research, Austin
- Local Institution - 1260, Dallas
- Epic Medical Research LLC - DeSoto, DeSoto
- и још 5
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 27. 10. 2026. · NCT06585787[18F]PI-2620 Phase 3 Histopathological Study
- Baylor Research Institute, Dallas
- Sante Clinical Research, Kerrville
Тражи се учесникФаза 3
Узраст 50 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT05641688A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Gadolin Research ( Site 1032), Beaumont
- Horizon Clinical Research Center - Houston ( Site 1026), Cypress
Тражи се учесникФаза 2
Узраст од 50 до 85 · Оба пола · Ажурирано 20. 10. 2026. · NCT07033494Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Gadolin Research, LLC, Beaumont
- South Texas Research Institute - Brownsville, Brownsville
- Kerwin Medical Center, Dallas
- и још 6
Тражи се учесникФаза 3
Узраст од 50 до 90 · Оба пола · Ажурирано 19. 10. 2026. · NCT07177352A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Mt. Olympus Medical Research, Llc - Katy, Katy
Тражи се учесникФаза 4
Узраст 50 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07633470A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Local Institution - 0081, Dallas
- Central Texas Neurology Consultants, PA, Round Rock
Тражи се учесникФаза 3
Узраст од 60 до 85 · Оба пола · Ажурирано 8. 10. 2026. · NCT06976203Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Kerwin Research Center, LLC - Oak Cliff, Dallas
- Kerwin Research Center, LLC in Texas, Dallas
Тражи се учесникФаза 2
Узраст од 55 до 80 · Оба пола · Ажурирано 7. 10. 2026. · NCT06847321Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Pinnacle Clinical Research, Austin
- Horizon Clinical Research Center - Houston, Cypress
- ANESC Research, El Paso
- и још 3
Тражи се учесникФаза 2
Узраст од 55 до 90 · Оба пола · Ажурирано 6. 10. 2026. · NCT06808984NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
- Baylor College of Medicine, Houston
Тражи се учесник
Узраст од 55 до 90 · Оба пола · Ажурирано 1. 10. 2026. · NCT07667478A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Kerwin Medical Center /ID# 277788, Dallas
Тражи се учесникФаза 1/2
Узраст од 50 до 90 · Оба пола · Ажурирано 18. 9. 2026. · NCT07599670Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline
- Health Discovery Building, Austin
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 90 · Оба пола · Ажурирано 2. 9. 2026. · NCT05907343Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- National Neuromuscular Research Institute, Austin
- University of Texas Southwestern, Dallas
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 8. 2026. · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Kerwin Research and Memory Center, Dallas
Тражи се учесникФаза 2/3Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 27. 7. 2026. · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Kerwin Research and Memory Center, Dallas
Тражи се учесникФаза 2/3Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 27. 7. 2026. · NCT05552157Epidemiology and Biomarker Study in Alzheimer's Disease
- Care Access - Houston, Houston
Тражи се учесникФаза 3Здраве особе су добродошле
Узраст од 55 до 75 · Оба пола · Ажурирано 7. 7. 2026. · NCT07142954Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
- University of Texas at Austin, Austin
Тражи се учесникРана фаза 1Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 10. 6. 2026. · NCT06511752Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
- University of Texas at Austin, Austin
Тражи се учесникЗдраве особе су добродошле
Узраст 40 и старији · Оба пола · Ажурирано 10. 6. 2026. · NCT05741853Trial-Ready Cohort-Down Syndrome (TRC-DS)
- University of Texas Health San Antonio, Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, San Antonio
Тражи се учесникОпсервациона студија
Узраст од 25 до 55 · Оба пола · Ажурирано 18. 5. 2026. · NCT04165109Late Onset Alzheimer's Disease
- University of Texas Southwestern, Dallas
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 55 и старији · Оба пола · Ажурирано 18. 5. 2026. · NCT05010603δ in Dementia Clinical Trials
- Univeristy of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio
Тражи се учесник
Узраст од 65 до 100 · Оба пола · Ажурирано 5. 5. 2026. · NCT05592678Stem Cell Therapy for Early Alzheimer's Disease
- The University of Texas Health Science Center at Houston (UTHealth), Houston
Тражи се учесникФаза 1/2
Узраст од 60 до 80 · Оба пола · Ажурирано 20. 4. 2026. · NCT06775964Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Gadolin Research LLC, Beaumont
- Re:Cognition Health, Houston
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 60 до 90 · Оба пола · Ажурирано 15. 4. 2026. · NCT06584357Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
- Houston Methodist Research Institute, Houston
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 18 до 90 · Оба пола · Ажурирано 6. 4. 2026. · NCT05582200Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms
- University of Texas Health Science Center at San Antonio, San Antonio
Тражи се учесник
Узраст од 60 до 85 · Оба пола · Ажурирано 11. 2. 2026. · NCT06801639Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Houston
Тражи се учесникФаза 2
Узраст од 50 до 85 · Оба пола · Ажурирано 2. 2. 2026. · NCT07105709Paper-Based and Smartphone-Based Memory Supports
- UT Health Austin Comprehensive Memory Center, Austin
- Baylor Scott & White Healthcare, Temple
- Baylor University, Waco
Тражи се учесник
Узраст 50 и старији · Оба пола · Ажурирано 9. 7. 2024. · NCT06444841Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- Caraday Healthcare, LLC, San Marcos
Тражи се учесник
Узраст 50 и старији · Оба пола · Ажурирано 12. 3. 2024. · NCT05820919Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- The University of Texas at Austin, Austin
Тражи се учесникФаза 4
Узраст 55 и старији · Оба пола · Ажурирано 18. 5. 2022. · NCT03082755Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.